{
    "abstract": "Background: Protection of newborns and young infants against RSV disease via maternal immunization mediated by transplacental transfer of antibodies is under evaluation in third-trimester pregnant women with the RSV recombinant F nanoparticle vaccine (RSV F vaccine). Since the hemichorial placental architecture in guinea pigs and humans is similar, the guinea pig model was employed to assess RSV F vaccine immunogenicity in pregnant sows and to compare RSV-specific maternal antibody levels in their pups. Methods: Thirty (30) presumptive pregnant guinea pigs were immunized on gestational day 25 and 46 with placebo (PBS), 30. \u03bcg RSV F, or 30. \u03bcg RSV F. +. 400. \u03bcg aluminum phosphate. Sera at delivery/birth (sows/pups) and 15 and 30 days post-partum (pups) were analyzed for the presence of anti-F IgG, palivizumab-competitive antibody (PCA) and RSV/A microneutralization (MN). Results: The rates of pregnancy and stillbirth were similar between controls and vaccinees. The vaccine induced high levels of anti-F IgG, PCA and MN in sows, with the highest levels observed in adjuvanted vaccinees. Placental transfer to pups was proportional to the maternal antibody levels, with concentration effects observed for all immune measures. Conclusions: The RSV F vaccine was safe and immunogenic in pregnant guinea pigs and supported robust transplacental antibody transfer to their pups. Relative concentration of antibodies in the pups was observed even in the presence of high levels of maternal antibody. Guinea pigs may be an important safety and immunogenicity model for preclinical assessment of candidate vaccines for maternal immunization.",
    "bib_entries": {
        "bib0140": {
            "authors": [
                {
                    "first": "Adeel Ahmed",
                    "initial": "A.A.",
                    "last": "Khan"
                },
                {
                    "first": "Aysha",
                    "initial": "A.",
                    "last": "Zahidie"
                },
                {
                    "first": "Fauziah",
                    "initial": "F.",
                    "last": "Rabbani"
                }
            ],
            "doi": "10.1186/1471-2458-13-322",
            "issn": "14712458",
            "pmid": "23570611",
            "pub_year": 2013,
            "title": "Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - A systematic review",
            "volume": "13"
        },
        "bib0145": {
            "authors": [
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Marion",
                    "initial": "M.",
                    "last": "Riffelmann"
                },
                {
                    "first": "Gurli",
                    "initial": "G.",
                    "last": "B\u00e4r"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Rudin"
                },
                {
                    "first": "Carl Heinz Wirsing",
                    "initial": "C.H.W.",
                    "last": "Von K\u00f6nig"
                }
            ],
            "doi": "10.1097/INF.0b013e318288b610",
            "firstpage": "695",
            "issn": "08913668",
            "lastpage": "698",
            "pmid": "23429559",
            "pub_year": 2013,
            "title": "The protective role of maternally derived antibodies against bordetella pertussis in young infants",
            "volume": "32"
        },
        "bib0150": {
            "authors": [
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Zaman"
                },
                {
                    "first": "Eliza",
                    "initial": "E.",
                    "last": "Roy"
                },
                {
                    "first": "Shams E.",
                    "initial": "S.E.",
                    "last": "Arifeen"
                },
                {
                    "first": "Mahbubur",
                    "initial": "M.",
                    "last": "Rahman"
                },
                {
                    "first": "Rubhana",
                    "initial": "R.",
                    "last": "Raqib"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Wilson"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                },
                {
                    "first": "Nigar S.",
                    "initial": "N.S.",
                    "last": "Shahid"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Breiman"
                },
                {
                    "first": "Mark C.",
                    "initial": "M.C.",
                    "last": "Steinhoff"
                }
            ],
            "doi": "10.1056/NEJMoa0708630",
            "firstpage": "1555",
            "issn": "00284793",
            "lastpage": "1564",
            "pmid": "18799552",
            "pub_year": 2008,
            "title": "Effectiveness of maternal influenza immunization in mothers and infants",
            "volume": "359"
        },
        "bib0155": {
            "authors": [
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "Englund"
                },
                {
                    "first": "W. Paul",
                    "initial": "W.P.",
                    "last": "Glezen"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                }
            ],
            "doi": "10.1016/S0264-410X(98)00108-X",
            "firstpage": "1456",
            "issn": "0264410X",
            "lastpage": "1463",
            "pmid": "9711788",
            "pub_year": 1998,
            "title": "Maternal immunization against viral disease",
            "volume": "16"
        },
        "bib0160": {
            "authors": [
                {
                    "first": "Allen C.",
                    "initial": "A.C.",
                    "last": "Enders"
                },
                {
                    "first": "Thomas N.",
                    "initial": "T.N.",
                    "last": "Blankenship"
                }
            ],
            "doi": "10.1016/S0169-409X(99)00003-4",
            "firstpage": "3",
            "issn": "0169409X",
            "lastpage": "15",
            "pub_year": 1999,
            "title": "Comparative placental structure",
            "volume": "38"
        },
        "bib0165": null,
        "bib0170": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Rath"
                },
                {
                    "first": "Kristi",
                    "initial": "K.",
                    "last": "Baker"
                },
                {
                    "first": "Michal",
                    "initial": "M.",
                    "last": "Pyzik"
                },
                {
                    "first": "Richard S.",
                    "initial": "R.S.",
                    "last": "Blumberg"
                }
            ],
            "doi": "10.3389/fimmu.2014.00664",
            "issn": "16643224",
            "pub_year": 2014,
            "title": "Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications",
            "volume": "5"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Brandtzaeg"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00338-4",
            "firstpage": "3382",
            "issn": "0264410X",
            "lastpage": "3388",
            "pmid": "12850345",
            "pub_year": 2003,
            "title": "Mucosal immunity: Integration between mother and the breast-fed infant",
            "volume": "21"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Marta C.",
                    "initial": "M.C.",
                    "last": "Nunes"
                },
                {
                    "first": "Clare L.",
                    "initial": "C.L.",
                    "last": "Cutland"
                }
            ],
            "doi": "10.1056/NEJMc1412050",
            "firstpage": "2340",
            "issn": "00284793",
            "pub_year": 2014,
            "title": "The authors reply",
            "volume": "371"
        },
        "bib0185": {
            "authors": [
                {
                    "first": "Mark C.",
                    "initial": "M.C.",
                    "last": "Steinhoff"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                },
                {
                    "first": "Eliza",
                    "initial": "E.",
                    "last": "Roy"
                },
                {
                    "first": "Shams El",
                    "initial": "S.E.",
                    "last": "Arifeen"
                },
                {
                    "first": "Rubhana",
                    "initial": "R.",
                    "last": "Raqib"
                },
                {
                    "first": "Caitlin",
                    "initial": "C.",
                    "last": "Dodd"
                },
                {
                    "first": "Robert F.",
                    "initial": "R.F.",
                    "last": "Breiman"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Zaman"
                }
            ],
            "doi": "10.1503/cmaj.110754",
            "firstpage": "645",
            "issn": "08203946",
            "lastpage": "653",
            "pub_year": 2012,
            "title": "Neonatal outcomes after influenza immunization during pregnancy: A randomized controlled trial",
            "volume": "184"
        },
        "bib0190": {
            "authors": [
                {
                    "first": "Gregory M.",
                    "initial": "G.M.",
                    "last": "Glenn"
                },
                {
                    "first": "Gale",
                    "initial": "G.",
                    "last": "Smith"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Fries"
                },
                {
                    "first": "Rama",
                    "initial": "R.",
                    "last": "Raghunandan"
                },
                {
                    "first": "Hanxin",
                    "initial": "H.",
                    "last": "Lu"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Zhou"
                },
                {
                    "first": "D. Nigel",
                    "initial": "D.N.",
                    "last": "Thomas"
                },
                {
                    "first": "Somia P.",
                    "initial": "S.P.",
                    "last": "Hickman"
                },
                {
                    "first": "Eloi",
                    "initial": "E.",
                    "last": "Kpamegan"
                },
                {
                    "first": "Sarathi",
                    "initial": "S.",
                    "last": "Boddapati"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.11.009",
            "firstpage": "524",
            "issn": "0264410X",
            "lastpage": "532",
            "pmid": "23153449",
            "pub_year": 2013,
            "title": "Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine",
            "volume": "31"
        },
        "bib0195": null,
        "bib0200": null,
        "bib0205": {
            "authors": [
                {
                    "first": "Bj\u00f6rn",
                    "initial": "B.",
                    "last": "Pasternak"
                },
                {
                    "first": "Henrik",
                    "initial": "H.",
                    "last": "Svanstrom\u0308"
                },
                {
                    "first": "Ditte",
                    "initial": "D.",
                    "last": "M\u00f8lgaard-Nielsen"
                },
                {
                    "first": "Tyra G.",
                    "initial": "T.G.",
                    "last": "Krause"
                },
                {
                    "first": "Hanne Dorthe",
                    "initial": "H.D.",
                    "last": "Emborg"
                },
                {
                    "first": "Mads",
                    "initial": "M.",
                    "last": "Melbye"
                },
                {
                    "first": "Anders",
                    "initial": "A.",
                    "last": "Hviid"
                }
            ],
            "doi": "10.1001/jama.2012.6131",
            "firstpage": "165",
            "issn": "00987484",
            "lastpage": "174",
            "pmid": "22782418",
            "pub_year": 2012,
            "title": "Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy",
            "volume": "308"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Richards"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Hansen"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Bredfeldt"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Bednarczyk"
                },
                {
                    "first": "Mark C.",
                    "initial": "M.C.",
                    "last": "Steinhoff"
                },
                {
                    "first": "Dzifa",
                    "initial": "D.",
                    "last": "Adjaye-Gbewonyo"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Ault"
                },
                {
                    "first": "Mia",
                    "initial": "M.",
                    "last": "Gallagher"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Orenstein"
                },
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Davis"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                }
            ],
            "doi": "10.1093/cid/cit045",
            "firstpage": "1216",
            "issn": "10584838",
            "lastpage": "1222",
            "pmid": "23378281",
            "pub_year": 2013,
            "title": "Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: Impact on preterm birth, birth weight, and small for gestational age birth",
            "volume": "56"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Neil E.",
                    "initial": "N.E.",
                    "last": "Simister"
                },
                {
                    "first": "Craig M.",
                    "initial": "C.M.",
                    "last": "Story"
                }
            ],
            "doi": "10.1016/S0165-0378(97)00068-5",
            "firstpage": "1",
            "issn": "01650378",
            "lastpage": "23",
            "pmid": "9501287",
            "pub_year": 1997,
            "title": "Human placental Fc receptors and the transmission of antibodies from mother to fetus",
            "volume": "37"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Gendrel"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Richard-lenoble"
                },
                {
                    "first": "M. B.",
                    "initial": "M.B.",
                    "last": "Massamba"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Picaud"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Francoual"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Blot"
                }
            ],
            "doi": "10.1093/tropej/36.6.279",
            "firstpage": "279",
            "issn": "01426338",
            "lastpage": "282",
            "pmid": "2280433",
            "pub_year": 1990,
            "title": "Placental transfer of tetanus antibodies and protection of the newborn",
            "volume": "36"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Neil E.",
                    "initial": "N.E.",
                    "last": "Simister"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00334-7",
            "firstpage": "3365",
            "issn": "0264410X",
            "lastpage": "3369",
            "pmid": "12850341",
            "pub_year": 2003,
            "title": "Placental transport of immunoglobulin G",
            "volume": "21"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "J. P.",
                    "initial": "J.P.",
                    "last": "van den Berg"
                },
                {
                    "first": "E. A.M.",
                    "initial": "E.A.M.",
                    "last": "Westerbeek"
                },
                {
                    "first": "F. R.M.",
                    "initial": "F.R.M.",
                    "last": "van der Klis"
                },
                {
                    "first": "G. A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Van Elburg"
                }
            ],
            "doi": "10.1016/j.earlhumdev.2010.11.003",
            "firstpage": "67",
            "issn": "03783782",
            "lastpage": "72",
            "pmid": "21123010",
            "pub_year": 2011,
            "title": "Transplacental transport of IgG antibodies to preterm infants: A review of the literature",
            "volume": "87"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Rama",
                    "initial": "R.",
                    "last": "Raghunandan"
                },
                {
                    "first": "Hanxin",
                    "initial": "H.",
                    "last": "Lu"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Zhou"
                },
                {
                    "first": "Mimi Guebre",
                    "initial": "M.G.",
                    "last": "Xabier"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Massare"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Flyer"
                },
                {
                    "first": "Louis F.",
                    "initial": "L.F.",
                    "last": "Fries"
                },
                {
                    "first": "Gale E.",
                    "initial": "G.E.",
                    "last": "Smith"
                },
                {
                    "first": "Gregory M.",
                    "initial": "G.M.",
                    "last": "Glenn"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.09.030",
            "firstpage": "6485",
            "issn": "0264410X",
            "lastpage": "6492",
            "pmid": "25269094",
            "pub_year": 2014,
            "title": "An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization",
            "volume": "32"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Gale",
                    "initial": "G.",
                    "last": "Smith"
                },
                {
                    "first": "Rama",
                    "initial": "R.",
                    "last": "Raghunandan"
                },
                {
                    "first": "Yingyun",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Ye",
                    "initial": "Y.",
                    "last": "Liu"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Massare"
                },
                {
                    "first": "Margret",
                    "initial": "M.",
                    "last": "Nathan"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Zhou"
                },
                {
                    "first": "Hanxin",
                    "initial": "H.",
                    "last": "Lu"
                },
                {
                    "first": "Sarathi",
                    "initial": "S.",
                    "last": "Boddapati"
                },
                {
                    "first": "Jingning",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Flyer"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Glenn"
                }
            ],
            "doi": "10.1371/journal.pone.0050852",
            "issn": "19326203",
            "pmid": "23226404",
            "pub_year": 2012,
            "title": "Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats",
            "volume": "7"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Helen Y.",
                    "initial": "H.Y.",
                    "last": "Chu"
                },
                {
                    "first": "Mark C.",
                    "initial": "M.C.",
                    "last": "Steinhoff"
                },
                {
                    "first": "Amalia",
                    "initial": "A.",
                    "last": "Magaret"
                },
                {
                    "first": "Khalequ",
                    "initial": "K.",
                    "last": "Zaman"
                },
                {
                    "first": "Eliza",
                    "initial": "E.",
                    "last": "Roy"
                },
                {
                    "first": "Gretchen",
                    "initial": "G.",
                    "last": "Langdon"
                },
                {
                    "first": "Mary Anne",
                    "initial": "M.A.",
                    "last": "Formica"
                },
                {
                    "first": "Edward E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                },
                {
                    "first": "Janet A.",
                    "initial": "J.A.",
                    "last": "Englund"
                }
            ],
            "doi": "10.1093/infdis/jiu316",
            "firstpage": "1582",
            "issn": "00221899",
            "lastpage": "1589",
            "pmid": "24903663",
            "pub_year": 2014,
            "title": "Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh",
            "volume": "210"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Rahaman O.",
                    "initial": "R.O.",
                    "last": "Suara"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Glezen"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Adegbola"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Weber"
                },
                {
                    "first": "Edward K.",
                    "initial": "E.K.",
                    "last": "Mulholland"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Hilton",
                    "initial": "H.",
                    "last": "Whittle"
                }
            ],
            "firstpage": "477",
            "issn": "1071412X",
            "lastpage": "479",
            "pmid": "8807217",
            "pub_year": 1996,
            "title": "Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in The Gambia and in the United States",
            "volume": "3"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Lone Graff",
                    "initial": "L.G.",
                    "last": "Stensballe"
                },
                {
                    "first": "Henrik",
                    "initial": "H.",
                    "last": "Ravn"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Kristensen"
                },
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "Agerskov"
                },
                {
                    "first": "Tiffany",
                    "initial": "T.",
                    "last": "Meakins"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Aaby"
                },
                {
                    "first": "Eric A.F.",
                    "initial": "E.A.F.",
                    "last": "Sim\u00f5es"
                }
            ],
            "doi": "10.1016/j.jaci.2008.10.043",
            "firstpage": "398",
            "issn": "00916749",
            "lastpage": "403",
            "pmid": "19101023",
            "pub_year": 2009,
            "title": "Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze",
            "volume": "123"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "LeFever"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Ishizaka"
                }
            ],
            "firstpage": "1698",
            "issn": "00221767",
            "lastpage": "1703",
            "pmid": "4113179",
            "pub_year": 1972,
            "title": "Half-life of guinea pig 1 globulin and 2 globulin antibodies.",
            "volume": "108"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Ochola"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Sande"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Fegan"
                },
                {
                    "first": "Paul D.",
                    "initial": "P.D.",
                    "last": "Scott"
                },
                {
                    "first": "Graham F.",
                    "initial": "G.F.",
                    "last": "Medley"
                },
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Cane"
                },
                {
                    "first": "D. James",
                    "initial": "D.J.",
                    "last": "Nokes"
                }
            ],
            "doi": "10.1371/journal.pone.0008088",
            "issn": "19326203",
            "pmid": "19956576",
            "pub_year": 2009,
            "title": "The level and duration of RSV-specific maternal IgG in infants in kilifi Kenya",
            "volume": "4"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Flor M.",
                    "initial": "F.M.",
                    "last": "Munoz"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                },
                {
                    "first": "W. Paul",
                    "initial": "W.P.",
                    "last": "Glezen"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00352-9",
            "firstpage": "3465",
            "issn": "0264410X",
            "lastpage": "3467",
            "pmid": "12850361",
            "pub_year": 2003,
            "title": "Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women",
            "volume": "21"
        }
    },
    "body_text": [
        {
            "endOffset": 15905,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 15807,
                    "startOffset": 15803
                }
            },
            "secId": "sec0030",
            "sentence": "Anti-RSV antibody levels based on anti-RSV F IgG and palivizumab-competitive binding with biotin-labeled palivizumab (MedImmune, LLC) were assessed at Novavax as previously described [11] on sera obtained from pregnant guinea pigs on PND0 and from their pups on PND0, PND15, and PND30.",
            "startOffset": 15620,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 25232,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Similar to previous studies in all species, AlPO4-adjuvanted RSV F vaccine administered to pregnant guinea pigs elicited a higher RSV F-specific antibody response than the unadjuvanted RSV F vaccine.",
            "startOffset": 25033,
            "title": "Discussion"
        },
        {
            "endOffset": 20196,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Pups assigned to PND0 were terminally bled to determine their anti-RSV F IgG titers, PCA concentrations, and RSV/A MN titers.",
            "startOffset": 20071,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 13608,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 13607,
                    "startOffset": 13603
                }
            },
            "secId": "sec0015",
            "sentence": "The RSV F vaccine was manufactured by infecting Spodoptera frugiperda cells in exponential growth with baculovirus containing the near full-length RSV F gene sequence, as previously described [11].",
            "startOffset": 13411,
            "title": "Vaccine"
        },
        {
            "endOffset": 27169,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 27168,
                    "startOffset": 27161
                },
                "bib0260": {
                    "endOffset": 27063,
                    "startOffset": 27059
                },
                "bib0265": {
                    "endOffset": 27168,
                    "startOffset": 27161
                }
            },
            "secId": "sec0065",
            "sentence": "The relatively short half-life, consistent with the literature on guinea pigs [25], does not reflect the general experience with transplacentally-derived human IgG directed to RSV [22,26].",
            "startOffset": 26981,
            "title": "Discussion"
        },
        {
            "endOffset": 10244,
            "parents": [],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 10243,
                    "startOffset": 10240
                }
            },
            "secId": "sec0005",
            "sentence": "In mammals, the passage of maternal antibodies to na\u00efve offspring is largely achieved by either in utero transplacental transfer of IgG or post-partum breast-feeding of colostral milk containing high levels of IgG and sIgA [5].",
            "startOffset": 10017,
            "title": "Introduction"
        },
        {
            "endOffset": 13380,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Although the guinea pig model is an immune na\u00efve model and may differ in some respects compared to adult women who are primed with years of repeat RSV infections, the results of this study represent a key dataset toward building a risk-benefit profile for use of the RSV F nanoparticle vaccine in pregnant women.",
            "startOffset": 13068,
            "title": "Introduction"
        },
        {
            "endOffset": 19630,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "Pregnant guinea pigs immunized with unadjuvanted and AlPO4-adjuvanted RSV F resulted in high anti-RSV F IgG titers (GMT = 20,620 and 374,506, respectively), with 18.2-fold higher RSV F IgG titers in adjuvanted vaccine recipients (Fig. 1A).",
            "startOffset": 19391,
            "title": "Evaluation of immune responses in guinea pig sows"
        },
        {
            "endOffset": 14227,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Thirty (30) presumed pregnant female Hartley guinea pigs were obtained from Charles River Laboratories, Canada, on the 20th day of gestation (GD20).",
            "startOffset": 14079,
            "title": "Animals"
        },
        {
            "endOffset": 26308,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Alternatively, the RSV F vaccine may elicit antibody responses of higher quality, characterized by increased binding affinity to the F protein, which may be more efficiently transferred.",
            "startOffset": 26122,
            "title": "Discussion"
        },
        {
            "endOffset": 15257,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Animals in Group 2 (30 \u03bcg RSV F) and Group 3 (30 \u03bcg RSV F + 400 \u03bcg AlPO4) received an IM administration of antigen alone or with adjuvant in a volume of 250 \u03bcL per guinea pig on GD25 and GD46 also.",
            "startOffset": 15060,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 23180,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 23158,
                    "startOffset": 23154
                },
                "bib0225": {
                    "endOffset": 23179,
                    "startOffset": 23175
                }
            },
            "secId": "sec0065",
            "sentence": "The active transport of IgG antibodies generally results in enhanced antibody concentrations in cord blood, often in excess of maternal levels [17] and favors IgG1 [18].",
            "startOffset": 23011,
            "title": "Discussion"
        },
        {
            "endOffset": 18528,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "In Group 3 (RSV F + AlP04), 9/10 females delivered 32 live and 3 stillborn pups indicating a delivery rate of 90%.",
            "startOffset": 18414,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 19845,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "Similarly, PCA concentrations obtained with unadjuvanted and AlPO4-adjuvanted RSV F were also robust (GMT = 139 and 1,553 \u03bcg/mL, respectively) and levels were 11.2-fold higher with the adjuvanted vaccine (Fig. 1B).",
            "startOffset": 19631,
            "title": "Evaluation of immune responses in guinea pig sows"
        },
        {
            "endOffset": 20672,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Pups born to unadjuvanted RSV F vaccinated sows had anti-RSV F IgG GMT of 63,036; PCA concentration of 292 \u03bcg/mL; and RSV/A MN GMT of 160 (Fig. 1).",
            "startOffset": 20525,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 26821,
            "parents": [],
            "secId": "sec0065",
            "sentence": "As noted, pups born to RSV F-immunized sows had robust anti-RSV F IgG, PCA, and neutralizing antibody levels in their serum.",
            "startOffset": 26697,
            "title": "Discussion"
        },
        {
            "endOffset": 21458,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "All remaining pups not assigned to PND0 were housed with their mother until weaning on PND15.",
            "startOffset": 21365,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 11239,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 11238,
                    "startOffset": 11235
                }
            },
            "secId": "sec0005",
            "sentence": "Although humans seem to lack, or at least have inefficient colostral/intestinal IgG antibody uptake, there is important and well-described documentation of neonatal Fc receptor-mediated transport of IgG across the epithelial barrier; i.e., from the systemic circulation to the mucosal surface and sampling of antigen-antibody complexes in the intestine by local immune cells [7].",
            "startOffset": 10860,
            "title": "Introduction"
        },
        {
            "endOffset": 13879,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The F protein, which forms nanoparticles of approximately 40 nm in diameter, was further formulated in buffer containing 25 mM sodium phosphate, pH 6.2, 1% histidine, 0.01% PS80 and then adsorbed to aluminum phosphate (AlPO4, Brenntag Biosector, Frederikssund, Denmark).",
            "startOffset": 13609,
            "title": "Vaccine"
        },
        {
            "endOffset": 25650,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 25601,
                    "startOffset": 25597
                }
            },
            "secId": "sec0065",
            "sentence": "The observed transplacental concentration of antibodies is similar, or possibly more robust to that generally observed in humans [19], with the exception of the MN antibody response.",
            "startOffset": 25468,
            "title": "Discussion"
        },
        {
            "endOffset": 15059,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Pregnant females in Group 1 (placebo) received an intramuscular (IM) administration of PBS in a volume of 250 \u03bcL per guinea pig on GD25 and 46.",
            "startOffset": 14916,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 18413,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "Similarly, 8/10 guinea pigs in Group 2 (RSV F alone) delivered 29 live (and 0 stillborn) pups, resulting in an 80% delivery rate.",
            "startOffset": 18284,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 10016,
            "parents": [],
            "refoffsets": {
                "bib0155": {
                    "endOffset": 10015,
                    "startOffset": 10012
                }
            },
            "secId": "sec0005",
            "sentence": "Maternal immunization is an important strategy to protect infants against RSV where the peak hospitalization rates occur in the youngest infants [4].",
            "startOffset": 9867,
            "title": "Introduction"
        },
        {
            "endOffset": 28524,
            "parents": [],
            "secId": "sec0070",
            "sentence": "The authors are employees of Novavax.",
            "startOffset": 28487,
            "title": "Conflict of interest statement"
        },
        {
            "endOffset": 25467,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Pups born to RSV F vaccinated sows had high levels of anti-RSV F IgG, PCA, and RSV/A neutralizing antibodies at birth, and concentration effects, relative to levels in matched maternal sera, was observed with all serological measures.",
            "startOffset": 25233,
            "title": "Discussion"
        },
        {
            "endOffset": 16141,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Titers were reported as the reciprocal dilution that resulted in a reading of 50% the maximum OD.",
            "startOffset": 16044,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 14820,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "All serologies were performed via orbital sinus or cardiac puncture following isoflurane inhalation or intraperitoneal injection of Euthansol, an euthanasia solution.",
            "startOffset": 14654,
            "title": "Animals"
        },
        {
            "endOffset": 20005,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "RSV/A MN levels in unadjuvanted RSV F vaccine recipients reached a GMT of 73, but were 9.8-fold higher (GMT of 718) in adjuvanted vaccine recipients (Fig. 1C).",
            "startOffset": 19846,
            "title": "Evaluation of immune responses in guinea pig sows"
        },
        {
            "endOffset": 20525,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "All the pups born to RSV F (both adjuvanted and unadjuvanted) vaccinated sows generated anti-RSV F specific immune responses indicating efficient maternal antibody transfer during the gestation period (Fig. 1).",
            "startOffset": 20315,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 27643,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Specific confirmation of the decay kinetics of these transplacentally-derived antibodies in humans may shed further light in determining whether the guinea pig is a suitable model to predict the half-life of RSV F-specific antibodies in humans.",
            "startOffset": 27399,
            "title": "Discussion"
        },
        {
            "endOffset": 21108,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Similarly, pups born to adjuvanted RSV F vaccinated sows had anti-RSV F IgG, PCA, and RSV/A neutralizing GMTs of 832,277; 2,427 \u03bcg/mL; and 1,194, respectively (Fig. 1).",
            "startOffset": 20940,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 12802,
            "parents": [],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 12800,
                    "startOffset": 12797
                }
            },
            "secId": "sec0005",
            "sentence": "An experimental RSV recombinant F nanoparticle vaccine (RSV F vaccine) has progressed to evaluation in third-trimester pregnant women (Clintrials.gov, NCT02247726), with earlier studies in women of childbearing age having shown the vaccine induces F protein specific antibodies as measured by several clinically relevant assays (i.e., anti-F IgG and palivizumab-competitive antibody (PCA) ELISA, and microneutralization [6]).",
            "startOffset": 12377,
            "title": "Introduction"
        },
        {
            "endOffset": 16317,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Titer values recorded as below the lower limit of detection (LLOD) were assigned a titer of <100 for the sample, and a titer of 50 for the geometric mean titer (GMT) analysis.",
            "startOffset": 16142,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 20940,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Importantly, antibody levels were higher compared to those measured in matched maternal sera (20,620; 139 \u03bcg/mL; and 73, for anti-RSV F IgG, PCA, and RSV/A MN, respectively), indicating a relative concentration of antibody in pups by 306, 210, and 219%, respectively.",
            "startOffset": 20673,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 15427,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Pups assigned to the PND0 (n = 14\u201317) phlebotomy cohort were terminally bled on delivery day.",
            "startOffset": 15334,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 18168,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "The overall rate of pregnancy achieved in this study was 83.3% (25/30 presumed pregnant guinea pigs delivered between GD61-71) with litter size range 1 to 8 (Table 2).",
            "startOffset": 18001,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 16867,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "To obtain the equivalent result in concentration, the titer value was multiplied by 2 \u03bcg/mL, a coefficient derived from several reference curves from multiple experiments (data not shown).",
            "startOffset": 16679,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 26980,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Levels declined after birth, but persisted through 30 days post-partum, and were notably highest in pups born to sows vaccinated with AlLPO4-adjuvanted RSV F.",
            "startOffset": 26822,
            "title": "Discussion"
        },
        {
            "endOffset": 23631,
            "parents": [],
            "secId": "sec0065",
            "sentence": "In this GLP study, pregnant guinea pigs were immunized with the clinical stage RSV F nanoparticle vaccine, and vaccine effects on rates of pregnancy and rates of live births were observed in a controlled setting.",
            "startOffset": 23419,
            "title": "Discussion"
        },
        {
            "endOffset": 22653,
            "parents": [],
            "refoffsets": {
                "bib0150": {
                    "endOffset": 22652,
                    "startOffset": 22640
                },
                "bib0185": {
                    "endOffset": 22652,
                    "startOffset": 22640
                },
                "bib0205": {
                    "endOffset": 22652,
                    "startOffset": 22640
                },
                "bib0210": {
                    "endOffset": 22652,
                    "startOffset": 22640
                }
            },
            "secId": "sec0065",
            "sentence": "Similarly, influenza immunization of pregnant women has demonstrated efficacy against influenza disease in both the woman and her infant, in the absence of any adverse impacts on either the course of the pregnancy or the neonate [3,10,14,15].",
            "startOffset": 22411,
            "title": "Discussion"
        },
        {
            "endOffset": 16043,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "For anti-F IgG, data was analyzed using SoftMax pro software (Molecular Devices) using a 4-parameter logistics (4-PL) curve fit analysis.",
            "startOffset": 15906,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 10537,
            "parents": [],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 10536,
                    "startOffset": 10533
                }
            },
            "secId": "sec0005",
            "sentence": "In these animals the intestinal uptake of maternally derived colostral antibody via intestinal Fc receptors results in high serum levels of antibodies [6].",
            "startOffset": 10382,
            "title": "Introduction"
        },
        {
            "endOffset": 19227,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "Anti-RSV F IgG responses, PCA, and RSV/A MN were measured in serum samples obtained from individual sows on the day of delivery, designated as Post Natal Day 0 (PND0).",
            "startOffset": 19060,
            "title": "Evaluation of immune responses in guinea pig sows"
        },
        {
            "endOffset": 22843,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 22842,
                    "startOffset": 22839
                }
            },
            "secId": "sec0065",
            "sentence": "Finally, the implementation of third-trimester maternal immunization with pertussis has had dramatic effects on the incidence of pertussis where the uptake of the vaccine has been high [2].",
            "startOffset": 22654,
            "title": "Discussion"
        },
        {
            "endOffset": 26553,
            "parents": [],
            "secId": "sec0065",
            "sentence": "The current trial of the RSV F nanoparticle vaccine in third-trimester pregnant women and their infants (Clin.",
            "startOffset": 26443,
            "title": "Discussion"
        },
        {
            "endOffset": 28077,
            "parents": [],
            "secId": "sec0065",
            "sentence": "It also demonstrates the transfer of placental anti-RSV F antibodies, as measured using different immunoassays, and concentration of these antibodies in pups in comparison to their respective birth mothers.",
            "startOffset": 27871,
            "title": "Discussion"
        },
        {
            "endOffset": 10381,
            "parents": [],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 10380,
                    "startOffset": 10377
                }
            },
            "secId": "sec0005",
            "sentence": "In ungulates, the transfer of antibodies from mother to infant occurs exclusively through colostral milk given at the first feeding [5].",
            "startOffset": 10245,
            "title": "Introduction"
        },
        {
            "endOffset": 23419,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 23369,
                    "startOffset": 23362
                },
                "bib0230": {
                    "endOffset": 23369,
                    "startOffset": 23362
                }
            },
            "secId": "sec0065",
            "sentence": "Accordingly, it is a reasonable expectation that raising functional anti-RSV F antibody levels in pregnant woman will increase titers of functional anti-RSV F antibodies in infants [18,19]; thus we endeavored to model this in guinea pigs.",
            "startOffset": 23181,
            "title": "Discussion"
        },
        {
            "endOffset": 27870,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 27869,
                    "startOffset": 27865
                }
            },
            "secId": "sec0065",
            "sentence": "In summary, this study provides further evidence that the RSV F vaccine may be safely administered during pregnancy\u2014a finding in line with the first in human study with a virus-derived purified F protein in pregnant women [27].",
            "startOffset": 27643,
            "title": "Discussion"
        },
        {
            "endOffset": 22309,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Maternal immunization has been most successfully implemented by a WHO global immunization campaign to address neonatal tetanus.",
            "startOffset": 22182,
            "title": "Discussion"
        },
        {
            "endOffset": 25807,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 25806,
                    "startOffset": 25799
                },
                "bib0250": {
                    "endOffset": 25806,
                    "startOffset": 25799
                }
            },
            "secId": "sec0065",
            "sentence": "Several studies in humans measuring MN antibodies derived from natural infection, have described a relative parity of infant and maternal MN levels [22,23].",
            "startOffset": 25651,
            "title": "Discussion"
        },
        {
            "endOffset": 26121,
            "parents": [],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 25925,
                    "startOffset": 25921
                }
            },
            "secId": "sec0065",
            "sentence": "This may be explained by the high variability of neutralizing antibodies elicited by natural infection in humans [24], whereas the vaccine, given at a consistent dose in na\u00efve guinea pigs, may induce a relatively constant MN titer (see 95% CI for example) that allows a more precise measure of placental transfer.",
            "startOffset": 25808,
            "title": "Discussion"
        },
        {
            "endOffset": 15554,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "The remaining pups (n = 14\u201317) that were left with birth mothers until weaning (i.e., on PND15), were bled on PND15 and PND30.",
            "startOffset": 15428,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 17166,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 17165,
                    "startOffset": 17161
                }
            },
            "secId": "sec0035",
            "sentence": "To determine whether passively transferred anti-RSV F antibodies and palivizumab can elicit RSV F neutralizing antibodies, sera samples from sows (PND0) and pups (PND0, PND15, PND30) were assayed in a RSV/A (Long strain) neutralization assay as previously described [11].",
            "startOffset": 16895,
            "title": "Microneutralization assay"
        },
        {
            "endOffset": 18000,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "Pregnant females carried to term and delivered pups between 61 and 71 days of gestation.",
            "startOffset": 17912,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 14653,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Guinea pigs were weighed upon arrival and randomized two days later based on similar body weight distribution into 1 of 3 treatment groups with 10 animals each.",
            "startOffset": 14493,
            "title": "Animals"
        },
        {
            "endOffset": 24348,
            "parents": [],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 24347,
                    "startOffset": 24340
                },
                "bib0200": {
                    "endOffset": 24347,
                    "startOffset": 24340
                }
            },
            "secId": "sec0065",
            "sentence": "Among the 9 stillbirths in the placebo group, 7 were from one guinea pig with a litter of 8 pups indicating the stillbirth was associated with the unusually large litter size compared to the average of 3 pups for this species [12,13].",
            "startOffset": 24114,
            "title": "Discussion"
        },
        {
            "endOffset": 24823,
            "parents": [],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 24822,
                    "startOffset": 24815
                },
                "bib0200": {
                    "endOffset": 24822,
                    "startOffset": 24815
                }
            },
            "secId": "sec0065",
            "sentence": "In general, these outcomes are in line with historical rates of pregnancy and stillbirth in lab-raised guinea pigs [12,13].",
            "startOffset": 24700,
            "title": "Discussion"
        },
        {
            "endOffset": 14078,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "The in-life portion of the study was performed under Good Laboratory Practice (GLP) regulations at Smithers Avanza (Gaithersburg, MD) to generate controlled pregnancy and pup delivery data.",
            "startOffset": 13889,
            "title": "Animals"
        },
        {
            "endOffset": 17538,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Sera that showed no inhibition in CPE at the 1:20 dilution were assigned a value of 10 for the GMT analysis.",
            "startOffset": 17430,
            "title": "Microneutralization assay"
        },
        {
            "endOffset": 19390,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "The titers for maternal samples in the placebo group were below the detection or minimum dilution level for the anti-RSV F IgG, PCA, and RSV/A MN assays (Fig. 1).",
            "startOffset": 19228,
            "title": "Evaluation of immune responses in guinea pig sows"
        },
        {
            "endOffset": 17911,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "In this study, three treatment groups of presumed pregnant guinea pigs received immunization with active vaccine or placebo in their third trimester on GD25 and 46.",
            "startOffset": 17747,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 14367,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "To improve the rate of pregnancy, guinea pigs with prior history of more than one successful pregnancy were selected for the current study.",
            "startOffset": 14228,
            "title": "Animals"
        },
        {
            "endOffset": 16678,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Titer values recorded below the LLOD were assigned a titer of <10 for the sample, and a titer of 5 for the GMT analysis.",
            "startOffset": 16558,
            "title": "Anti-RSV F IgG ELISA and palivizumab-competitive antibody ELISA"
        },
        {
            "endOffset": 17697,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "The GMT (anti-RSV F IgG and RSV/A MN) or GMC (PCA) and associated 95% confidence interval (CI) were calculated for each treatment group.",
            "startOffset": 17561,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24002,
            "parents": [],
            "secId": "sec0065",
            "sentence": "The overall pregnancy rate was 83.3% for all three treatment groups, with a litter size range of 1 to 8 pups, for a total of 94 live births and 12 stillbirths.",
            "startOffset": 23843,
            "title": "Discussion"
        },
        {
            "endOffset": 23010,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 23009,
                    "startOffset": 23005
                }
            },
            "secId": "sec0065",
            "sentence": "In humans, maternal IgG antibodies are transplacentally-transferred to the fetus by active transcytosis facilitated by IgG Fc receptors expressed on the placenta [16].",
            "startOffset": 22843,
            "title": "Discussion"
        },
        {
            "endOffset": 13067,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In support of this work, the guinea pig model was employed to further assess the immunogenicity of this experimental vaccine in pregnant sows and to compare antibody levels placentally-transferred to their pups using the same immunological measures aforementioned.",
            "startOffset": 12803,
            "title": "Introduction"
        },
        {
            "endOffset": 17263,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Two-fold serial dilutions of guinea pig sera, starting at 1:10, were prepared in 96-well plates.",
            "startOffset": 17167,
            "title": "Microneutralization assay"
        },
        {
            "endOffset": 11571,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The precise mechanism underlying this protection is unclear, but may be due to direct contact between antibodies in milk and pathogens in the upper respiratory tract and gut.",
            "startOffset": 11397,
            "title": "Introduction"
        },
        {
            "endOffset": 12010,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As the acceptance of maternal immunization via transplacental transfer grows as a viable strategy for protection of newborns against disease early in life, so does the urgency to develop robust safety and immunogenicity datasets in a relevant preclinical model.",
            "startOffset": 11749,
            "title": "Introduction"
        },
        {
            "endOffset": 20314,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "The GMTs for pups born to sows that received placebo were very low or below the detection level for all three assays.",
            "startOffset": 20197,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 24699,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Overall, the delivery rates and the number of pups born between the placebo group and the active vaccine groups were similar, indicating RSV F vaccination of pregnant guinea pigs did not result in adverse effects on gestation.",
            "startOffset": 24473,
            "title": "Discussion"
        },
        {
            "endOffset": 12376,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The hemichorial placental architecture in guinea pigs reflects the anatomy found in humans and thus represents a potentially appropriate model to evaluate placental transfer of antibodies.",
            "startOffset": 12188,
            "title": "Introduction"
        },
        {
            "endOffset": 22171,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Given that pups continued to breastfeed through PND15 and intestinal Fc receptor-mediated antibody uptake is a significant mechanism to attain high-level serum titers post-partum, the half-life of RSV F antibodies was not calculated.",
            "startOffset": 21938,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 14492,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "In addition, females were not palpated or bled during the gestation period to avoid stress to the pregnant sows and fetuses.",
            "startOffset": 14368,
            "title": "Animals"
        },
        {
            "endOffset": 19008,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "The two remaining stillbirths in the placebo group and the 3 stillbirths in the adjuvanted RSV F group, involved only 1 pup per female; indicating the stillbirths were not related to vaccine administration as it occurred with similar frequency in the placebo and the adjuvanted RSV F vaccine groups.",
            "startOffset": 18709,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 26697,
            "parents": [],
            "secId": "sec0065",
            "sentence": "trials.gov, NCT02247726) is designed to measure the placental transfer of these antibodies, and will either confirm or reject these hypotheses.",
            "startOffset": 26554,
            "title": "Discussion"
        },
        {
            "endOffset": 9866,
            "parents": [],
            "refoffsets": {
                "bib0140": {
                    "endOffset": 9865,
                    "startOffset": 9860
                },
                "bib0145": {
                    "endOffset": 9865,
                    "startOffset": 9860
                },
                "bib0150": {
                    "endOffset": 9865,
                    "startOffset": 9860
                }
            },
            "secId": "sec0005",
            "sentence": "Protection of newborns and young infants against infectious disease via maternal immunization is an increasingly utilized intervention with strikingly effective outcomes [1\u20133].",
            "startOffset": 9690,
            "title": "Introduction"
        },
        {
            "endOffset": 24113,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Among the stillborn pups, 9 were in the placebo group (21.4%) and 3 were in the adjuvanted RSV F group (8.6%).",
            "startOffset": 24003,
            "title": "Discussion"
        },
        {
            "endOffset": 27398,
            "parents": [],
            "secId": "sec0065",
            "sentence": "There are several factors, including the comparatively more rapid increase in relative body weight (compared to human infants) and subsequent increase in volume of distribution for serum antibodies that may explain this finding.",
            "startOffset": 27170,
            "title": "Discussion"
        },
        {
            "endOffset": 15333,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Guinea pigs (sows) were bled on Post Natal Day (PND) 0 (i.e., at delivery).",
            "startOffset": 15258,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 14915,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Presumed pregnant guinea pigs were immunized as described in Table 1.",
            "startOffset": 14846,
            "title": "Guinea pig immunization"
        },
        {
            "endOffset": 17429,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "The neutralizing antibody titer was identified as the last dilution that resulted in 60% inhibition of cytopathic effect (CPE) observed in virus-only infected wells.",
            "startOffset": 17264,
            "title": "Microneutralization assay"
        },
        {
            "endOffset": 21365,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "As seen for the RSV F treatment group, antibody levels were higher in the pups compared to matched sows (374,506; 1,553 \u03bcg/mL; and 718, respectively), indicating a relative concentration of antibody in pup sera by 222, 156, and 166%, respectively (Fig. 2).",
            "startOffset": 21109,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 24472,
            "parents": [],
            "secId": "sec0065",
            "sentence": "All of the other stillbirths that occurred in the placebo and the adjuvanted RSV F groups involved only one pup per female.",
            "startOffset": 24349,
            "title": "Discussion"
        },
        {
            "endOffset": 10715,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Poor outcomes due to common pathogens in otherwise healthy newborn animals are frequently observed when colostral feeding does not occur (e.g., maternal demise during delivery).",
            "startOffset": 10538,
            "title": "Introduction"
        },
        {
            "endOffset": 25032,
            "parents": [],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 25031,
                    "startOffset": 25027
                },
                "bib0235": {
                    "endOffset": 25003,
                    "startOffset": 24999
                },
                "bib0240": {
                    "endOffset": 25014,
                    "startOffset": 25010
                }
            },
            "secId": "sec0065",
            "sentence": "Robust anti-RSV F IgG, PCA concentrations, and RSV/A neutralizing titers were detected in sera from RSV F vaccinated sows, consistent with previous observations in cotton rats [20], mice [21], and humans [11].",
            "startOffset": 24823,
            "title": "Discussion"
        },
        {
            "endOffset": 10859,
            "parents": [],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 10858,
                    "startOffset": 10855
                }
            },
            "secId": "sec0005",
            "sentence": "For human infants, maternal-derived IgG appears to be provided entirely in utero, via transplacental Fc receptor-mediated antibody transfer [5].",
            "startOffset": 10715,
            "title": "Introduction"
        },
        {
            "endOffset": 11396,
            "parents": [],
            "refoffsets": {
                "bib0175": {
                    "endOffset": 11395,
                    "startOffset": 11392
                }
            },
            "secId": "sec0005",
            "sentence": "While it is clear that human breast milk contains both polyclonal IgG and IgA and confers protection against respiratory and enteric illness in general [8].",
            "startOffset": 11240,
            "title": "Introduction"
        },
        {
            "endOffset": 22410,
            "parents": [],
            "refoffsets": {
                "bib0140": {
                    "endOffset": 22409,
                    "startOffset": 22406
                }
            },
            "secId": "sec0065",
            "sentence": "Since the program's inception, the incidence of neonatal tetanus has been significantly reduced [1].",
            "startOffset": 22310,
            "title": "Discussion"
        },
        {
            "endOffset": 18283,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "In Group 1 (placebo), 8/10 females delivered 33 live and 9 stillborn pups, which resulted in an 80% delivery rate.",
            "startOffset": 18169,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 12187,
            "parents": [],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 12186,
                    "startOffset": 12183
                }
            },
            "secId": "sec0005",
            "sentence": "The placental structure supports the physiologic transfer of nutrients, oxygen and antibodies to the fetus\u2014a function achieved without admixing of maternal and fetal blood [5].",
            "startOffset": 12011,
            "title": "Introduction"
        },
        {
            "endOffset": 26442,
            "parents": [],
            "secId": "sec0065",
            "sentence": "It is also possible the guinea pig model may not be a suitable paradigm to model human placental antibody transfer as measured by MN.",
            "startOffset": 26309,
            "title": "Discussion"
        },
        {
            "endOffset": 11749,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 11748,
                    "startOffset": 11740
                },
                "bib0160": {
                    "endOffset": 11675,
                    "startOffset": 11672
                },
                "bib0180": {
                    "endOffset": 11748,
                    "startOffset": 11740
                },
                "bib0185": {
                    "endOffset": 11748,
                    "startOffset": 11740
                }
            },
            "secId": "sec0005",
            "sentence": "Conversely, the protective effects of human serum IgG, transferred from mothers to infants in utero [5], has been well-described against many infectious disease agents [2,9,10].",
            "startOffset": 11572,
            "title": "Introduction"
        },
        {
            "endOffset": 23842,
            "parents": [],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 23693,
                    "startOffset": 23689
                }
            },
            "secId": "sec0065",
            "sentence": "When assessed in the context of the published literature [12], no untoward effects were observed as all pregnant guinea pigs vaccinated with unadjuvanted or adjuvanted RSV F on GD25 and 46 carried to full-term.",
            "startOffset": 23632,
            "title": "Discussion"
        },
        {
            "endOffset": 28457,
            "parents": [],
            "secId": "sec0065",
            "sentence": "Although further evaluation of the safety of the vaccine in pregnant women and their infants should be approached with caution, the disease burden in humans and the preclinical safety, immunogenicity, efficacy, and transplacental transfer data collectively underscore that development of the RSV F vaccine to protect mothers and their infants against RSV disease should continue.",
            "startOffset": 28078,
            "title": "Discussion"
        },
        {
            "endOffset": 18708,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 18707,
                    "startOffset": 18700
                },
                "bib0200": {
                    "endOffset": 18707,
                    "startOffset": 18700
                }
            },
            "secId": "sec0050",
            "sentence": "One female from Group 1 delivered 7 stillborn from a litter of 8 pups due to the large litter size (8) compared to an average of 3 seen with most females for this species [12,13].",
            "startOffset": 18529,
            "title": "Rate of pregnancy and pup survivability"
        },
        {
            "endOffset": 21756,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Relative to PND0 antibody levels, anti-RSV F IgG, PCA, and RSV/A MN GMTs/concentrations declined on PND15 in all pups of both RSV F vaccine recipients (GMT/concentration of 14,863; 68 \u03bcg/mL; and 44, respectively) and adjuvanted RSV F vaccine recipients (159,263; 521 \u03bcg/mL; and 333, respectively).",
            "startOffset": 21459,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        },
        {
            "endOffset": 21937,
            "parents": [
                {
                    "id": "sec0045",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Although further decreases in antibodies were noted at PND30; detectable levels remained, demonstrating the persistence of maternally-transferred RSV F-specific antibodies in pups.",
            "startOffset": 21757,
            "title": "Evaluation of RSV F vaccine induced maternal antibodies in pups"
        }
    ],
    "docId": "S0264410X15011664",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "gglenn@novavax.com",
                "first": "Gregory M.",
                "initial": "G.M.",
                "last": "Glenn"
            },
            {
                "email": null,
                "first": "Louis F.",
                "initial": "L.F.",
                "last": "Fries"
            },
            {
                "email": null,
                "first": "Gale",
                "initial": "G.",
                "last": "Smith"
            },
            {
                "email": null,
                "first": "Eloi",
                "initial": "E.",
                "last": "Kpamegan"
            },
            {
                "email": null,
                "first": "Hanxin",
                "initial": "H.",
                "last": "Lu"
            },
            {
                "email": null,
                "first": "Mimi",
                "initial": "M.",
                "last": "Guebre-Xabier"
            },
            {
                "email": null,
                "first": "Somia P.",
                "initial": "S.P.",
                "last": "Hickman"
            },
            {
                "email": null,
                "first": "David",
                "initial": "D.",
                "last": "Flyer"
            }
        ],
        "doi": "10.1016/j.vaccine.2015.08.039",
        "firstpage": "6488",
        "issn": "0264410X",
        "keywords": [
            "Anti-F IgG",
            "Guinea pig",
            "Hemichorial placenta",
            "Maternal immunization",
            "Microneutralization",
            "Palivizumab-competitive antibody",
            "RSV",
            "RSV F nanoparticle vaccine",
            "Transplacental antibody transfer"
        ],
        "lastpage": "6492",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs"
    }
}